Mechanisms of epileptogenesis and potential treatment targets.
about
Identification of new epilepsy treatments: issues in preclinical methodologyRecent treatment advances and novel therapeutic approaches in epilepsyAdenosine kinase: exploitation for therapeutic gain.The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocolMicroRNAs in the pathophysiology and treatment of status epilepticusEpilepsy related to traumatic brain injury.Issues related to development of antiepileptogenic therapies.Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s)Anti-epileptogenic clinical trial designs in epilepsy: issues and optionsEtiology matters - Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy.Adult Deletion of SRF Increases Epileptogenesis and Decreases Activity-Induced Gene Expression.MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsyInactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.Identification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and ProteinsUp-regulated cytoplasmic FMRP-interacting protein 1 in intractable temporal lobe epilepsy patients and a rat modelEpilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task ForceInfluence of aspirin on pilocarpine-induced epilepsy in mice.Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effectsEpigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategiesRNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis.Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approachesCerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticusMicroRNA and epilepsy: profiling, functions and potential clinical applications.Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction.Neuronal calcium signaling pathways are associated with the development of epilepsyReview: Hippocampal sclerosis in epilepsy: a neuropathology review.Validation of suitable reference genes for expression studies in different pilocarpine-induced models of mesial temporal lobe epilepsy.Alterations in miRNA levels in the dentate gyrus in epileptic rats.Age-dependent changes in intrinsic neuronal excitability in subiculum after status epilepticus.Validation of the rat model of cryptogenic infantile spasms.Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy.Antioxidants as a preventive treatment for epileptic process: a review of the current status.Caffeine prevents acute mortality after TBI in rats without increased morbidity.Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in HippocampusEpileptogenesis in organotypic hippocampal cultures has limited dependence on culture medium composition.Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury.Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.
P2860
Q24289140-B0B2CC2A-BE7B-4369-812E-290AC0603992Q26824512-7DBEEA55-6D32-488C-B213-E8C2CF3C17BAQ26852056-F5A3CC92-29A8-4FE8-99E1-ED56B05C6EDEQ26997757-5D099B8D-73F0-48A8-A7ED-84EC4C4734A5Q27004814-6CC34575-5128-4F74-8F75-315E6E93BCFEQ27013517-131DA8A1-62DC-4D65-8387-AF34130025D5Q27016115-98521A79-9B42-429B-8F63-DDEC00839C69Q27022004-7A3E21C4-3334-4FD4-89E4-8DBB0721081EQ27027689-818A94C0-266B-4475-AE1F-BDD2BF4CC8E6Q27316575-845D025F-BEA2-4F71-808F-D268A0C9E8D9Q27345329-2770F303-7462-4441-A0CC-A6BBBF688880Q27346840-D728F84B-8247-46E5-8641-0A7ED7D80E3BQ28268192-1803CF65-E2FC-4798-AB04-6AA5E35A3714Q28548040-2E0CFADE-3903-4F8A-9CE9-257948517ADCQ28572188-62A60949-BC7D-4DDC-8880-103E73ED4EFFQ28595920-429A867D-C300-46F7-A494-63C0B3043780Q30457930-AB1A8EAE-AD82-4D91-8904-202BE3229544Q30524857-2A1C3164-02B1-4CBA-B8B0-1EAC0B6F9B26Q30541877-A0292641-BDCA-4908-BB9B-296390729078Q30557209-A3B56519-41E0-4978-A018-A7B5C682B347Q30576762-0DB6DE54-6CCE-4F78-B4F0-AB41E9471815Q30836611-AEDFBF07-FE7A-4CC8-92FA-096E3D1B6B41Q33354141-C049CE92-E0B4-4F4D-BE04-2FD873647263Q33789438-53A7EEDE-10D4-472C-9F2A-DC2E5938A7DDQ34023217-1F04EBB1-118E-4764-92B4-88CAA6D1BA4DQ34339959-A0B5449A-8EBC-459F-B14F-64D23050BF7FQ34540827-AE4191EA-C073-4F0A-84DD-0CBBEB65F4F2Q34692930-A98014B8-5C10-4E97-B733-B42B0A7567E4Q34979494-93F7BAAF-1C14-4D12-8CFA-0F7FCCE1CAE5Q35022607-C7986FDA-F7F9-4E99-B22B-46BD5507C8FFQ35181005-A3A8216D-06F7-4C03-9444-5E2CD896CA43Q35204574-A41F9A20-F513-4D32-89E6-00895D8313EFQ35533933-B87174C1-A7CF-4D54-BE3A-E433DA9D753BQ35595421-3E55B803-3E26-4379-B0AA-C6762D5A5D44Q35803244-F4F983E0-7BEC-4D73-8DD0-44B09C3C9E41Q35962195-E7461FA7-31F5-4340-A7A7-5E4426CE16CBQ36099036-699F3A55-ADEB-46F3-9EB7-468C262E205DQ36287500-EACF3D38-B581-4589-9EEE-E6DCF8BD8FBBQ36300714-29A236B0-FD1A-4FBA-820E-158B9BFCC558Q36354351-B4FCE0E7-CCF3-4BC1-8703-23B0CC5B2F91
P2860
Mechanisms of epileptogenesis and potential treatment targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of epileptogenesis and potential treatment targets.
@en
Mechanisms of epileptogenesis and potential treatment targets.
@nl
type
label
Mechanisms of epileptogenesis and potential treatment targets.
@en
Mechanisms of epileptogenesis and potential treatment targets.
@nl
prefLabel
Mechanisms of epileptogenesis and potential treatment targets.
@en
Mechanisms of epileptogenesis and potential treatment targets.
@nl
P1433
P1476
Mechanisms of epileptogenesis and potential treatment targets.
@en
P2093
Asla Pitkänen
Katarzyna Lukasiuk
P304
P356
10.1016/S1474-4422(10)70310-0
P577
2011-02-01T00:00:00Z